MedPath

武汉九珑人福药业有限责任公司

Ownership
-
Established
2009-10-23
Employees
-
Market Cap
-
Website
www.jlrfyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Progesterone Soft Capsules

Product Name
黄体酮软胶囊
Approval Number
国药准字H20254199
Approval Date
May 20, 2025
NMPA

Progesterone Soft Capsules

Product Name
黄体酮软胶囊
Approval Number
国药准字H20254198
Approval Date
May 20, 2025
NMPA

Methylprednisolone Tablets

Product Name
甲泼尼龙片
Approval Number
国药准字H20254178
Approval Date
May 13, 2025
NMPA

Dienogest Tablets

Product Name
地诺孕素片
Approval Number
国药准字H20249426
Approval Date
Nov 22, 2024
NMPA

Abiraterone acetate Tablets

Product Name
醋酸阿比特龙片
Approval Number
国药准字H20244845
Approval Date
Sep 10, 2024
NMPA

Mifepristone Tablets

Product Name
米非司酮片
Approval Number
国药准字H20033551
Approval Date
Jun 7, 2024
NMPA

Ibuprofen Suspension

Product Name
迪尔诺
Approval Number
国药准字H10980022
Approval Date
Jun 7, 2024
NMPA

Mifepristone Capsules

Product Name
碧韵
Approval Number
国药准字H20051435
Approval Date
Jan 22, 2024
NMPA

Compound Mifepristone Tablets

Product Name
紫韵
Approval Number
国药准字H20040365
Approval Date
Oct 30, 2023
NMPA

Cyproterone Acetate Tablets

Product Name
醋酸环丙孕酮片
Approval Number
国药准字H20056637
Approval Date
Oct 30, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.